AstraZeneca PLC Ordinary Shares (AZN)

Total Current Assets

$27.93B

Quarterly · Period ending: · USD

AZN logo

AZN Total Current Assets

Latest reported$27.93B
AZN Quarterly Current Assets ($4.89B → $27.93B)
High-resolution chart · PNG

AZN total current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Total Current Assets — Quarterly (USD)
Period endingTotal Current Assets (USD)
27,932,342,000
29,613,000,000
28,723,000,000
29,940,000,000
28,939,000,000
26,139,000,000
25,827,000,000
24,155,000,000
25,393,000,000
25,594,000,000
25,054,000,000
22,501,000,000
22,839,000,000
22,266,000,000
22,593,000,000
20,224,000,000
20,917,000,000
22,647,000,000
26,244,000,000
26,691,000,000
27,274,000,000
18,735,000,000
19,544,000,000
18,166,000,000
14,930,000,000
12,822,000,000
15,563,000,000
13,520,000,000
15,219,000,000
13,649,000,000
15,591,000,000
13,108,000,000
12,449,000,000
13,182,000,000
13,150,000,000
13,634,000,000
14,298,000,000
11,637,000,000
13,262,000,000
12,866,000,000
13,320,000,000
12,769,000,000
16,007,000,000
13,199,000,000
13,812,000,000
12,691,000,000
16,697,000,000
15,072,000,000
16,204,000,000
16,542,000,000
20,335,000,000
18,792,000,000
19,394,000,000
18,344,000,000
19,048,000,000
18,029,000,000
19,777,000,000
21,560,000,000
23,506,000,000
22,467,000,000
22,691,000,000
23,467,000,000
25,131,000,000
24,569,000,000
23,376,000,000
22,347,000,000
23,760,000,000
20,540,000,000
19,126,000,000
15,852,000,000
16,152,000,000
15,570,000,000
16,476,000,000
14,452,000,000
17,082,000,000
14,691,000,000
16,078,000,000
16,286,000,000
16,936,000,000
14,433,000,000
15,051,000,000
16,936,000,000
13,770,000,000
13,095,000,000
13,438,000,000
13,770,000,000
14,440,000,000
12,253,000,000
11,911,000,000
13,261,000,000
12,933,000,000
12,996,000,000
12,265,081,177
12,950,312,702
12,126,000,000
11,531,604,481
11,419,734,179
11,772,225,283
14,820,502,680
11,159,814,070
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.